# Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation

> **NCT04324528** · NA · COMPLETED · sponsor: **Dr. Alexander Supady** · enrollment: 34 (actual)

## Conditions studied

- Coronavirus
- COVID-19
- SARS-CoV Infection
- Respiratory Failure
- Cytokine Storm

## Interventions

- **DEVICE:** vv-ECMO + cytokine adsorption (Cytosorb adsorber)
- **DEVICE:** vv-ECMO only (no cytokine adsorption)

## Key facts

- **NCT ID:** NCT04324528
- **Lead sponsor:** Dr. Alexander Supady
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-27
- **Primary completion:** 2021-01-27
- **Final completion:** 2021-01-27
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04324528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04324528, "Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04324528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*